Reunion Neuroscience (TSX:REUN) YoY EPS Growth : 54.84% (As of Mar. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Reunion Neuroscience YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Reunion Neuroscience's YoY EPS Growth for the quarter that ended in Mar. 2023 was 54.84%.

Reunion Neuroscience's Earnings per Share (Diluted) for the three months ended in Mar. 2023 was C$-0.56.

Reunion Neuroscience YoY EPS Growth Historical Data

The historical data trend for Reunion Neuroscience's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Reunion Neuroscience YoY EPS Growth Chart

Reunion Neuroscience Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

YoY EPS Growth

-911.56

-35.71

12.21

Reunion Neuroscience Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
YoY EPS Growth	Get a 7-Day Free Trial										-37.78	-4.55	-22.12	17.69	54.84

Reunion Neuroscience YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Reunion Neuroscience's YoY EPS Growth for the fiscal year that ended in Mar. 2023 is calculated as:

	YoY EPS Growth (A: Mar. 2023 )
=	(Earnings per Share (Diluted) (A: Mar. 2023 )	-	Earnings per Share (Diluted) (A: Mar. 2022 ))	/	\| Earnings per Share (Diluted) (A: Mar. 2022 ) \|
=	(-4.17	-	-4.75)	/	\| -4.75 \|
=	12.21 %

Reunion Neuroscience's YoY EPS Growth for the quarter that ended in Mar. 2023 is calculated as:

	YoY EPS Growth (Q: Mar. 2023 )
=	(Earnings per Share (Diluted) (Q: Mar. 2023 )	-	Earnings per Share (Diluted) (Q: Mar. 2022 ))	/	\| Earnings per Share (Diluted) (Q: Mar. 2022 )) \|
=	(-0.56	-	-1.24)	/	\| -1.24 \|
=	54.84 %

Reunion Neuroscience YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Reunion Neuroscience's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Reunion Neuroscience (TSX:REUN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Reunion Neuroscience Inc (TSX:REUN) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

30 Duncan Street, Lower North Suite, Toronto, ON, CAN, M5V 2C3

Website

https://www.reunionneuro.com

Reunion Neuroscience Inc is engaged in novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company's asset, RE-104 (previously known as FT-104), is a proprietary, novel psychedelic drug being developed for post-partum and treatment-resistant depression as a potential fast-acting antidepressant with durable efficacy.